Alta Semper is a specialist private equity firm investing flexible capital in the healthcare, health-tech and consumer sectors, across high-growth emerging economies. Sector focus and expertise combined are an important source of value creation and positive impact. Alta Semper was founded by Afsane Jetha, Richard D. Parsons and members of the Estée Lauder family to bring a differentiated strategy to investing in growth markets; the firm now has over 200 years of combined specialist experience across investment and operating roles, based across key regional hubs.
Thematic Investor
Significant Institutional Investor Backing
Supporting Best-in-Class Management Teams
Focus on Future Proofing Technology
Targeted Sectors
Healthcare
Investment Strategy:
Democratize access to affordable and quality Healthcare products and services
- Primary Care
- Specialized Clinics
- Laboratories, Diagnostics, and Imaging
- Pharmaceutical Manufacturing / Retail
Consumer Healthcare / Consumer Staples
Investment Strategy:
Democratize access to affordable and quality Consumer Staples
- Personal Care Products
- Strategic Import Substitution
- Food, Beverage & Nutritional Supplements
- Household Goods
Education / Vocational Training
Investment Strategy:
Democratize access to affordable and quality Post-Secondary Education
- Tertiary Education
- Vocational Education
- Continuing Education & Upskilling
- Technical Training
Technology Overlay
Democratize access and solve industry pain points through disruptive tech and enabling infrastructure aligned with our priority sectors
I. Low-Cost, Mobile Medical Equipment
II. Digital Health Solutions
III. Last Mile Enabling Software
IV. Supply Chain & Logistics
V. Enabling Financial Services
VI. Ed-Tech
Approach
- Controlling stakes / active value creation
- Active minority for earlier stage portfolio
- 20% earlier stage growth equity
- Focus on bringing developed markets tech to emerging markets
- Industry-leading strategic operating partners
Investment
- Unparalleled expertise across emerging market regions
- Strong local networks and proven track record
- Healthcare & consumer thematic specialization is unique
- Cross-regional knowledge transfer
- Over 50 years of cumulative specialist expertise in healthcare and consumer-facing goods and services
Impact
- Focus on mobilising capital into high impact opportunities
- We ensure we are working towards achieving the UN Sustainable Development Goals
- Mass market healthcare, affordability & accessibility at the heart of our investment mandate
- Dedicated teams responsible for implementing and tracking impact and ESG performance in our portfolio
Portfolio Strategy
Africa is an extremely diverse continent. We focus on twelve large, highly diversified, politically stable and fast-growing economies and regions. These are regions in which we have a strong local network, along with a successful track record of structuring and growing consumer and healthcare companies.
Elite Investment Platform: Team & Track Record
Alta Semper Leadership Team & Performance
Operational excellence is achieved through the insights and experience of industry-leading strategic operating partners and strong management teams
Total Investments
Capital Deployed
Track Record of Senior Team Over Career Span
Total Exits
Alta Semper's Senior Team have Invested in and Advised on Several Landmark EM and DM Transactions Over the Last 25+ Years
Investment Highlights
Kenya’s leading all-in-one health platform
Founded in 2017, MyDawa enables consumers to conveniently purchase authentic high-quality medicines, health and wellness products through partnerships with healthcare practitioners and suppliers. It is the largest e-pharmacy in East Africa, focused on pharmaceutical, OTC, and personal care products.
Initial Investment Date: 2021
Headquarters: Nairobi, Kenya
Industry: E-pharmacy, telemedicine, primary care and diagnostics
Leading innovator & manufacturer of artificial kidneys
Headquartered in the United Kingdom, Allmed is a world class provider and innovator of blood purification solutions and artificial kidneys, with pioneering research and development centres in Germany. It is the leading enabler and supplier of these life-saving treatments to the global south.
Initial Investment Date: 2024
Headquarters: London, United Kingdom
Industry: Artificial kidneys, dialysis consumables, dialysis machinery and renal pharmaceuticals
News
Kenya’s MyDawa aims to be an all-in-one health platform backed by $20 million funding
03 Jul 2023
